Marc Lustig

Marc Lustig

Chief Executive Officer at PHARMACIELO LTD.

Net worth: 2 M $ as of 2026-05-30

53 year
Finance
Process Industries
Health Technology

Profile

Marc Lustig was the founder of CannaRoyalty Corp., founded in 2015, serving as Executive Chairman & Chief Executive Officer from 2018 to 2020.
Mr. Lustig was the founder of Trichome Financial Corp., founded in 2017, serving as Chairman from 2017 to 2021.
Mr. Lustig is the founder of Cannabis Royalties & Holdings Corp., founded in 2015, serving as Chief Executive Officer & Director from 2015 to 2020.
Mr. Lustig is also the founder of Cedars Cancer Foundation.
Mr. Lustig is Chairman & Chief Executive Officer at PharmaCielo Ltd. since 2023.
Mr. Lustig is Director at Cresco Labs LLC.
Mr. Lustig is Independent Director at Aequus Pharmaceuticals, Inc. since 2021.
Mr. Lustig is Director at Resolve Digital Health, Inc. Mr. Lustig is Director at L5 Capital, Inc. Mr. Lustig is Director at Cresco Labs, Inc. (Arizona) since 2021.
Mr. Lustig is Director at Cresco Labs, Inc. since 2020.
Mr. Lustig was Chairman at META Growth Corp.
from 2018 to 2020.
Mr. Lustig was Chairman at Trichome Financial Corp.
Mr. Lustig was Chairman at Wellfield Technologies, Inc. from 2021 to 2023.
Mr. Lustig was Executive Chairman at IM Cannabis Corp.
from 2019 to 2024.
Mr. Lustig was Director at RF Capital Group, Inc. Mr. Lustig was Independent Director at 22 Capital Corp.
Mr. Lustig was Independent Director at Planet 13 Holdings, Inc. from 2018 to 2019.
Mr. Lustig was Independent Director at BriaCell Therapeutics Corp.
from 2021 to 2024.
Mr. Lustig was Head-Capital Markets at Merck & Co., Inc. Mr. Lustig was Principal at Griffiths McBurney Corp.
Mr. Lustig was Head-Capital Markets at Dundee Capital Markets, Inc. from 2012 to 2014.
Mr. Lustig was Sales Associate at GMP Securities LP.
Mr. Lustig was Vice President at Orion Securities, Inc. Mr. Lustig was Principal at KES 7 Capital, Inc. Mr. Lustig completed graduate and MBAistration degrees at McGill University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-15 24,262,580 ( 12.91% ) 2 M $ 2026-05-30
2026-02-22 192,232 ( 0.06% ) 176 277 $ 2026-05-30
2025-04-20 10,198,958 ( 4.92% ) 71 393 $ 2026-05-30
2024-12-09 17,403 ( 0.24% ) 63 347 $ 2026-05-30
2025-09-23 6,916,666 ( 5.21% ) 6 917 $ 2026-05-30
2025-07-31 1,589 ( 99.94% ) 1 457 $ 2026-05-30

Marc Lustig active positions

CompaniesPositionStart
PHARMACIELO LTD. Chief Executive Officer 2023-07-09
CRESCO LABS INC. Director/Board Member 2020-07-28
AEQUUS PHARMACEUTICALS INC. Director/Board Member 2021-02-14
Director/Board Member -
Director/Board Member -
Director/Board Member -

Former positions of Marc Lustig

CompaniesPositionEnd
BRIACELL THERAPEUTICS CORP. Director/Board Member 2024-11-22
NAVASOTA RESOURCES INC Chairman 2024-06-04
WELLFIELD TECHNOLOGIES INC. Chairman 2023-10-05
░░░░░░░░ ░░░░░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░░
See the detail of Marc Lustig's experience

Training of Marc Lustig

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

19

1st degree connections

25

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies25

Health Technology

Process Industries

Finance

Finance

Process Industries

Health Technology

Finance

Finance

Consumer Services

Finance

Finance

Health Technology

Process Industries

Process Industries

Health Technology

Finance

Retail Trade

Process Industries

Finance

Process Industries

Process Industries

Cedars Cancer Foundation

Finance

Finance

Finance

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!